• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart.旁分泌机制在心脏干细胞修复和再生作用中的作用。
J Mol Cell Cardiol. 2011 Feb;50(2):280-9. doi: 10.1016/j.yjmcc.2010.08.005. Epub 2010 Aug 19.
2
Myocardial regeneration: the role of progenitor cells derived from bone marrow and heart.心肌再生:骨髓和心脏来源的祖细胞的作用。
Prog Mol Biol Transl Sci. 2012;111:195-215. doi: 10.1016/B978-0-12-398459-3.00009-5.
3
Application of Stem Cell Technologies to Regenerate Injured Myocardium and Improve Cardiac Function.干细胞技术在再生受损心肌及改善心脏功能方面的应用。
Cell Physiol Biochem. 2019;53(1):101-120. doi: 10.33594/000000124.
4
Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure.控制心脏自分泌和旁分泌信号:心力衰竭治疗的新策略。
Heart Fail Rev. 2010 Nov;15(6):531-42. doi: 10.1007/s10741-010-9165-7.
5
Stem cells: the building blocks to repair the injured heart.干细胞:修复受损心脏的基石。
Panminerva Med. 2010 Jun;52(2):97-110.
6
Cardiovascular regenerative therapeutics via synthetic paracrine factor modified mRNA.通过合成旁分泌因子修饰的信使核糖核酸进行心血管再生治疗
Stem Cell Res. 2014 Nov;13(3 Pt B):693-704. doi: 10.1016/j.scr.2014.06.007. Epub 2014 Jul 8.
7
Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome.通过使用人羊膜间充质干细胞 secretome 的旁分泌增强作用来激活心脏再生的内源性机制。
Int J Cardiol. 2019 Jul 15;287:87-95. doi: 10.1016/j.ijcard.2019.04.011. Epub 2019 Apr 4.
8
Lost and found: cardiac stem cell therapy revisited.失而复得:再探心脏干细胞疗法
J Clin Invest. 2006 Jul;116(7):1838-40. doi: 10.1172/JCI29050.
9
Paracrine effects of cell transplantation: modifying ventricular remodeling in the failing heart.细胞移植的旁分泌效应:改善衰竭心脏的心室重塑
Semin Thorac Cardiovasc Surg. 2008 Summer;20(2):87-93. doi: 10.1053/j.semtcvs.2008.04.001.
10
Cardiac regeneration: stem cells and beyond.心脏再生:干细胞及其他。
Curr Med Chem. 2012;19(35):5993-6002. doi: 10.2174/092986712804485935.

引用本文的文献

1
Current status and new horizons in stem cell therapy in cardiovascular regenerative medicine (CaVaReM): an update.心血管再生医学(CaVaReM)中干细胞治疗的现状与新视野:最新进展
Eur J Med Res. 2025 Sep 3;30(1):837. doi: 10.1186/s40001-025-03018-z.
2
A review of regenerative medicine and tissue engineering with a focus on wound healing and anti-aging.再生医学与组织工程综述:聚焦伤口愈合与抗衰老
Front Surg. 2025 Jun 5;12:1504563. doi: 10.3389/fsurg.2025.1504563. eCollection 2025.
3
Cell-free extracts from human fat tissue attenuate ischemic injury in cardiomyocytes in a murine model.在小鼠模型中,来自人体脂肪组织的无细胞提取物可减轻心肌细胞的缺血性损伤。
World J Stem Cells. 2025 May 26;17(5):105394. doi: 10.4252/wjsc.v17.i5.105394.
4
Stem Cell Therapy for Myocardial Infarction Recovery: Advances, Challenges, and Future Directions.用于心肌梗死恢复的干细胞疗法:进展、挑战与未来方向
Biomedicines. 2025 May 16;13(5):1209. doi: 10.3390/biomedicines13051209.
5
Injectable Stem Cell-Based Therapies for Myocardial Regeneration: A Review of the Literature.用于心肌再生的基于干细胞的注射疗法:文献综述
J Funct Biomater. 2025 Apr 23;16(5):152. doi: 10.3390/jfb16050152.
6
Myocardial infarction serum preconditioning bone marrow mesenchymal stem cell-derived exosomes enhance anti-fibrosis in rat myocardial infarction hearts.心肌梗死血清预处理的骨髓间充质干细胞来源的外泌体增强大鼠心肌梗死心脏的抗纤维化作用。
Mol Cell Biochem. 2025 Apr 1. doi: 10.1007/s11010-025-05273-4.
7
Umbilical Cord Matrix (Wharton Jelly) Mesenchymal Stem Cells in Next-generation Myocardial Repair and Regeneration: Mechanisms and Pre-clinical Evidence.脐带基质(华通胶)间充质干细胞在下一代心肌修复与再生中的作用:机制与临床前证据
Curr Cardiol Rev. 2025;21(5):76-103. doi: 10.2174/011573403X372908250117092252.
8
Umbilical cord-derived mesenchymal stromal cells: Promising therapy for heart failure.脐带间充质基质细胞:心力衰竭的有前景的治疗方法。
World J Cardiol. 2025 Jan 26;17(1):101153. doi: 10.4330/wjc.v17.i1.101153.
9
The paradigm of stem cell secretome in tissue repair and regeneration: Present and future perspectives.组织修复与再生中干细胞分泌组的范例:现状与未来展望。
Wound Repair Regen. 2025 Jan-Feb;33(1):e13251. doi: 10.1111/wrr.13251.
10
Bibliometrics of trends in global research on the roles of stem cells in myocardial fibrosis therapy.全球干细胞在心肌纤维化治疗中作用的研究趋势的文献计量学
World J Stem Cells. 2024 Dec 26;16(12):1086-1105. doi: 10.4252/wjsc.v16.i12.1086.

本文引用的文献

1
Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors.经冠状动脉内注射间充质干细胞衍生的生长因子可改善梗死心脏的功能和心肌修复。
J Cardiovasc Transl Res. 2010 Oct;3(5):547-58. doi: 10.1007/s12265-010-9171-0. Epub 2010 Feb 26.
2
Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton.成体骨髓间充质干细胞在骨骼疾病中的治疗潜力。
J Cell Biochem. 2010 Oct 1;111(2):249-57. doi: 10.1002/jcb.22701.
3
Stanniocalcin-1 regulates extracellular ATP-induced calcium waves in human epithelial cancer cells by stimulating ATP release from bystander cells.钙结合蛋白 1 通过刺激旁观者细胞释放 ATP 来调节人上皮癌细胞中外源 ATP 诱导的钙波。
PLoS One. 2010 Apr 20;5(4):e10237. doi: 10.1371/journal.pone.0010237.
4
New insights into paracrine mechanisms of human cardiac progenitor cells.对人心肌祖细胞旁分泌机制的新认识。
Eur J Heart Fail. 2010 Jul;12(7):730-7. doi: 10.1093/eurjhf/hfq063. Epub 2010 Apr 20.
5
Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.过表达 CCR1 的间充质干细胞的基因修饰可增加损伤心肌中的细胞活力、迁移、植入和毛细血管密度。
Circ Res. 2010 Jun 11;106(11):1753-62. doi: 10.1161/CIRCRESAHA.109.196030. Epub 2010 Apr 8.
6
Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells.内皮祖细胞分泌的旁分泌因子可防止氧化应激诱导的成熟内皮细胞凋亡。
Atherosclerosis. 2010 Jul;211(1):103-9. doi: 10.1016/j.atherosclerosis.2010.02.022. Epub 2010 Feb 24.
7
Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases.利用肝素递呈纳米纤维捕获干细胞旁分泌效应治疗心血管疾病。
J Tissue Eng Regen Med. 2010 Dec;4(8):600-10. doi: 10.1002/term.273.
8
Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury.Toll 样受体 2 在急性缺血再灌注损伤后介导间充质干细胞相关的心肌恢复和血管内皮生长因子的产生。
Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1529-36. doi: 10.1152/ajpheart.01087.2009. Epub 2010 Feb 19.
9
Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.STRO-1 表达的富集增强了人骨髓间充质细胞群体的心血管旁分泌活性。
J Cell Physiol. 2010 May;223(2):530-40. doi: 10.1002/jcp.22081.
10
microRNAs in heart disease: putative novel therapeutic targets?心脏病中的微小RNA:潜在的新型治疗靶点?
Eur Heart J. 2010 Mar;31(6):649-58. doi: 10.1093/eurheartj/ehp573. Epub 2010 Jan 29.

旁分泌机制在心脏干细胞修复和再生作用中的作用。

Paracrine mechanisms of stem cell reparative and regenerative actions in the heart.

机构信息

Department of Medicine, Duke University Medical Center & Mandel Center for Hypertension and Atherosclerosis Research, Durham, NC 27710, USA.

出版信息

J Mol Cell Cardiol. 2011 Feb;50(2):280-9. doi: 10.1016/j.yjmcc.2010.08.005. Epub 2010 Aug 19.

DOI:10.1016/j.yjmcc.2010.08.005
PMID:20727900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3021634/
Abstract

Stem cells play an important role in restoring cardiac function in the damaged heart. In order to mediate repair, stem cells need to replace injured tissue by differentiating into specialized cardiac cell lineages and/or manipulating the cell and molecular mechanisms governing repair. Despite early reports describing engraftment and successful regeneration of cardiac tissue in animal models of heart failure, these events appear to be infrequent and yield too few new cardiomyocytes to account for the degree of improved cardiac function observed. Instead, mounting evidence suggests that stem cell mediated repair takes place via the release of paracrine factors into the surrounding tissue that subsequently direct a number of restorative processes including myocardial protection, neovascularization, cardiac remodeling, and differentiation. The potential for diverse stem cell populations to moderate many of the same processes as well as key paracrine factors and molecular pathways involved in stem cell-mediated cardiac repair will be discussed in this review. This article is part of a special issue entitled, "Cardiovascular Stem Cells Revisited".

摘要

干细胞在受损心脏中恢复心脏功能方面发挥着重要作用。为了进行修复,干细胞需要通过分化为特定的心脏细胞谱系来替代受损组织,和/或操纵控制修复的细胞和分子机制。尽管早期有报道描述了心力衰竭动物模型中干细胞的移植和心脏组织的成功再生,但这些事件似乎很少发生,产生的新心肌细胞太少,无法解释观察到的心脏功能改善程度。相反,越来越多的证据表明,干细胞介导的修复是通过旁分泌因子释放到周围组织中实现的,随后这些旁分泌因子指导许多修复过程,包括心肌保护、血管生成、心脏重构和分化。本综述将讨论多种干细胞群体调节许多相同过程以及参与干细胞介导的心脏修复的关键旁分泌因子和分子途径的潜力。本文是题为“心血管干细胞再探”的特刊的一部分。